植物化学
益生菌
发酵
生物
传统医学
生物技术
肠道菌群
抗氧化剂
中医药
类黄酮
牲畜
饲料添加剂
食品科学
戒毒(替代医学)
药理学
功能性食品
脂肪酸
药用植物
生物活性化合物
乳酸
医学
生物利用度
动物健康
短链脂肪酸
公认安全
健康福利
作者
Yisheng ZHANG,Zhengshun WANG,DAWAQIONGDA DAWAQIONGDA,刘弘明,徐业芬,Zeyan HUANG,Qinghui KONG
标识
DOI:10.9775/kvfd.2026.37510
摘要
Intestinal inflammation, underpinned by gut dysbiosis, epithelial barrier dysfunction and dysregulated TLR4/NF-κB-mediated innate immunity, represents a major constraint on livestock production efficiency and animal welfare.Traditional Chinese herbal medicines (TCHMs) possess multi-component, multi-target anti-inflammatory profiles and favourable safety margins; however, their therapeutic efficacy is limited by poor oral bioavailability, extensive first-pass metabolism and substantial pharmacokinetic variability.Microbial fermentation can remodel herbal constituents through polysaccharide depolymerisation, flavonoid glycoside hydrolysis, phenolic acid liberation and alkaloid/tannin modification, potentially yielding metabolites with improved bioaccessibility and intestinal anti-inflammatory activity.This narrative review synthesises current evidence on fermentation-mediated phytochemical transformation of Chinese medicinal herbs and the intestinal health effects of the resulting preparations in production animals.Fermentation microorganisms, metabolic profiles and conditiondependent phytochemical transformations are critically examined and integrated with tissue-level protective mechanisms encompassing gut microbiota remodelling, shortchain fatty acid metabolism, epithelial tight-junction reinforcement, suppression of aberrant TLR4/MyD88/NF-κB signalling and pathological NLRP3 inflammasome activation, as well as Nrf2-dependent antioxidant defence.Evidence obtained directly from fermented herbal preparations in production animals is explicitly delineated from that extrapolated from general probiotic or short-chain fatty acid (SCFA) literature.Importantly, much of the mechanistic evidence remains preclinical, and few studies have validated efficacy, optimal dosing or safety under commercial production conditions.Finally, a "strain-ingredient-metabolite-microbiota-host" mechanistic framework is proposed to guide the standardisation of fermentation protocols, quality control and the veterinary application of fermented TCHMs.
科研通智能强力驱动
Strongly Powered by AbleSci AI